Covered recipient · General Payments record
WILLIAM JOHN LORMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$1,144.98
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $432.95 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.38 | 12 |
| ITI, Inc. | $114.50 | 1 |
| Axsome Therapeutics, Inc. | $42.14 | 2 |
| Lundbeck LLC | $34.23 | 2 |
| Otsuka America Pharmaceutical, Inc. | $17.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1.27 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556816 | CMS |
| ABBVIE INC. | $3.85 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556818 | CMS |
| ABBVIE INC. | $18.47 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556820 | CMS |
| ABBVIE INC. | $3.44 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556822 | CMS |
| ABBVIE INC. | $124.99 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556824 | CMS |
| ABBVIE INC. | $3.44 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556826 | CMS |
| ABBVIE INC. | $3.60 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556828 | CMS |
| ABBVIE INC. | $3.59 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556830 | CMS |
| ABBVIE INC. | $18.18 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556832 | CMS |
| ABBVIE INC. | $15.82 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556834 | CMS |
| ABBVIE INC. | $8.35 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556836 | CMS |
| ABBVIE INC. | $19.38 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556838 | CMS |
| Axsome Therapeutics, Inc. | $23.34 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148419564 | CMS |
| Axsome Therapeutics, Inc. | $18.80 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148419566 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $114.50 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143536039 | CMS |
| Lundbeck LLC | $14.32 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146052971 | CMS |
| Lundbeck LLC | $19.91 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146052973 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.70 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119124954 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.